 | Tonix Pharmaceuticals Announces Publication of Patent Application for TNX-1500 (Monoclonal Antibody Anti-CD40-Ligand) in Development for Preventing and Treating Organ Transplant Rejection and Treating Autoimmune Conditions
finance.yahoo.com - January 14 at 4:33 PM |
| Tonix Pharmaceuticals Holdings Corp. Closes $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - January 13 at 8:28 PM |
 | 5 Penny Stocks to Watch If Biotech Stocks Are Your Focus in January 2021
marketwatch.com - January 13 at 3:21 PM |
 | Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up to $0.93
americanbankingnews.com - January 13 at 11:54 AM |
| Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 13.5%
americanbankingnews.com - January 12 at 7:14 PM |
| Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock Offering Priced at-the-Market Under Nasdaq Rules
finance.yahoo.com - January 11 at 6:10 PM |
 | Tonix Pharmaceuticals prices $40M equity offering
seekingalpha.com - January 11 at 1:52 PM |
| Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7%
americanbankingnews.com - January 7 at 12:10 AM |
 | Tonix Pharmaceuticals to Participate in Upcoming January Conferences
benzinga.com - January 5 at 4:32 PM |
| Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up to $0.72
americanbankingnews.com - January 5 at 10:58 AM |
|
| Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix’s Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection
finance.yahoo.com - January 5 at 8:54 AM |
| Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 5.9%
americanbankingnews.com - January 4 at 9:34 PM |
| Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 6.2%
americanbankingnews.com - December 29 at 7:54 PM |
| Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up to $0.66
americanbankingnews.com - December 24 at 11:12 AM |
| Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 15.5%
americanbankingnews.com - December 23 at 7:36 PM |
| Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
finance.yahoo.com - December 22 at 8:43 AM |
| Tonix Pharmaceuticals Reports Topline Results from Phase 3 RECOVERY Study of TNX-102 SL in PTSD and Outlines Future Development Plans
finance.yahoo.com - December 21 at 8:05 AM |
| TNXP: Positive Results for TNX-102 SL in Phase 3 RELIEF Trial…
finance.yahoo.com - December 15 at 1:26 PM |
| Tonix Pharmaceuticals Announces Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia
benzinga.com - December 7 at 7:15 AM |
| Vaccine Genome Researchers Report 99.7% Colinear Identity Between a U.S. Civil War Era Smallpox Vaccine and Horsepox Virus
finance.yahoo.com - December 4 at 6:53 PM |
| TNXP: Animal Data for SARS-CoV-2 Vaccine Candidate Shows Robust Immune Response…
finance.yahoo.com - November 30 at 1:30 PM |
| Tonix Pharma's COVID-19 vaccine candidate shows encouraging preclinical action
seekingalpha.com - November 16 at 12:19 PM |
| Tonix Pharmaceuticals Reports Positive Immune Response Results from COVID-19 Vaccine Candidate TNX-1800, Following Vaccination of Non-Human Primates
finance.yahoo.com - November 16 at 7:18 AM |
| Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit
finance.yahoo.com - November 12 at 6:54 PM |
| Tonix Pharmaceuticals to Present at the virtual Fall Investor Summit on November 16th-18th
finance.yahoo.com - November 12 at 8:52 AM |
| Tonix Pharmaceuticals to Participate in Upcoming November Conferences
finance.yahoo.com - November 11 at 7:48 AM |
| Tonix Pharmaceuticals to Present at 3rd Annual Neuropsychiatric Drug Development Summit
finance.yahoo.com - November 9 at 6:24 PM |
| Tonix Pharmaceuticals EPS beats by $0.02
seekingalpha.com - November 9 at 1:24 PM |
|
| Tonix Provides Updates For Fibromyalgia, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - October 28 at 2:15 AM |
| Tonix Pharmaceuticals Enrolls First Participant in the PRECISION Study, an Observational Study to Facilitate Development of Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics
finance.yahoo.com - October 22 at 3:49 PM |
| Tonix Pharma launches observational study facilitating development of tailored COVID-19 vaccines and therapeutics
seekingalpha.com - October 15 at 10:34 AM |
 | Tonix Pharmaceuticals CEO on Vaccine Progress (Podcast)
bloomberg.com - October 14 at 2:27 AM |
| Tonix Pharma to conclude TNX-102 SL late-stage study with currently enrolled chronic disorder patients
seekingalpha.com - September 29 at 6:25 PM |
| Tonix Pharma to conclude TNX-102 late-stage study with currently enrolled chronic disorder patients
seekingalpha.com - September 29 at 6:25 PM |
| Tonix Pharmaceuticals to Host Live Webinar: Antibody vs. T Cell Immunity: Is a Single Vaccine Enough to Stop COVID-19?
finance.yahoo.com - September 17 at 2:14 PM |
| Enrollment underway in Tonix Pharma's observational study in COVID-19
seekingalpha.com - September 15 at 1:07 PM |
| Tonix Pharmaceuticals Enrolls First Patient in COV-LOGIC, an Observational Study to Assess Antibody and T Cell Responses to SARS-CoV-2, the Virus that Causes COVID-19
finance.yahoo.com - September 15 at 1:07 PM |
| TNXP: Interim Analysis for Phase 3 RELIEF Trial in Sep. 2020; Preclinical data for TNX-1800 in 4Q20…
finance.yahoo.com - September 3 at 5:47 PM |
| Enrollment underway in Tonix Pharma's Phase 3 RALLY study for fibromyalgia
seekingalpha.com - September 3 at 12:47 PM |
| Tonix Pharmaceuticals Initiates Enrollment in Second Potentially Pivotal Phase 3 Study, the RALLY Study, of TNX-102 SL for the Management of Fibromyalgia
finance.yahoo.com - September 3 at 12:47 PM |
| Insider Buys Tonix Pharmaceuticals's Stock
finance.yahoo.com - September 1 at 6:07 PM |
| Insider Buys Tonix Pharmaceuticals's Stock
benzinga.com - September 1 at 1:07 PM |
| Tonix Pharmaceuticals to Participate in Upcoming September Virtual Investor Conferences
finance.yahoo.com - August 27 at 12:29 PM |
| With Key Data Nearing, Tonix Looks to Spotlight Robust Pipeline In Immunology And CNS Therapeutics
finance.yahoo.com - August 26 at 10:38 AM |
| Insider Buys Tonix Pharmaceuticals Shares
benzinga.com - August 24 at 12:23 PM |
| Insider Buys Tonix Pharmaceuticals Stock
benzinga.com - August 19 at 12:46 PM |
| Tonix Pharmaceuticals Holding Corp (TNXP) CEO Seth Lederman Bought $54,600 of Shares
finance.yahoo.com - August 17 at 1:16 PM |
| Tonix Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
finance.yahoo.com - August 10 at 1:12 PM |
| Tonix Pharma on go with study of TNX-102 SL in alcohol use disorder
seekingalpha.com - August 6 at 1:07 PM |
| Tonix Pharmaceuticals Announces Clearance of IND for TNX-102 SL for Treatment of Alcohol Use Disorder
finance.yahoo.com - August 6 at 1:07 PM |
